Who is sponsoring NCT03618498?

NCT03618498 is sponsored by Changhua Christian Hospital.

What drugs are being tested in NCT03618498?

Interventions in NCT03618498: ILM flaps insertion techniques or free ILM flaps..

What condition does NCT03618498 study?

NCT03618498 studies Retinal Detachment.

Is NCT03618498 still recruiting?

NCT03618498 is currently completed. Last updated 8 August 2018.

Last reviewed 2018-08-08 · How we verify

NCT03618498: ILMFCMHRDPDR

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Internal Limiting Membrane Flaps for Coexistent Macular Hole and Retinal Detachment

Completed NA Last updated 8 August 2018

What this trial tests

NA trial testing ILM flaps insertion techniques or free ILM flaps. in Retinal Detachment in 10 participants. Completed in 15 July 2018.

Timeline

7 March 2018

Primary endpoint
31 May 2018

15 July 2018

Quick facts

Lead sponsor	Changhua Christian Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Design	sequential
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	7 March 2018
Primary completion	31 May 2018
Estimated completion	15 July 2018
Sites	1 location across Taiwan

Drugs / interventions tested

ILM flaps insertion techniques or free ILM flaps.

Conditions studied

Retinal Detachment — all drugs for Retinal Detachment →

Sponsor

Changhua Christian Hospital

Who can join

Eligibility, any sex, with Retinal Detachment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose: To evaluate the logical surgical approaches in closing macular holes in eyes of proliferative diabetic retinopathy with retinal detachment

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Retinal Detachment

Currently open trials in the same condition.

NCT06587945 — Nicotinamide Riboside Oral Supplementation in Macula Off Retinal Detachment · Phase 4 · recruiting
NCT06985030 — Head Position Monitoring After Pars Planar Vitrectomy · active not recruiting
NCT06830070 — Subjective Pain Scoring for Subtenonal Anesthesia During Vitrectomy · active not recruiting
NCT03713268 — Intraoperative OCT Guidance of Intraocular Surgery II · recruiting

Other Changhua Christian Hospital trials

Trials by the same sponsor.

NCT07040215 — Effects on Subacute Stroke With Robotic Assistive Gait Training · NA · recruiting
NCT06970834 — Explore the Effect of Bitter Melon Peptides on Glycemic Control and Metabolic Indicators in Diabetic Patients · NA · not yet recruiting
NCT06432153 — Tampa Scale of Kinesiophobia for Heart Taiwan Version Validation · not yet recruiting
NCT06334237 — Psychosomatic Factors Influencing the Efficacy of Holistic Care for Migraine · recruiting
NCT06118294 — Efficacy of Probiotics for Parkinson Disease (PD) · NA · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03618498 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Changhua Christian Hospital
Last refreshed: 8 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03618498.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing